Jadenu and Nausea and vomiting - a phase IV clinical study of FDA data
Summary:
Nausea and vomiting is reported as a side effect among people who take Jadenu (deferasirox), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Exjade, and have Iron overload.
The phase IV clinical study analyzes which people have Nausea and vomiting when taking Jadenu. It is created by eHealthMe based on reports of 4,173 people who have side effects when taking Jadenu from the FDA, and is updated regularly.
What is Jadenu?
Jadenu has active ingredients of deferasirox. eHealthMe is studying from 4,176 Jadenu users. Check the latest studies of Jadenu.
What is Nausea and vomiting?
Nausea and vomiting is found to be associated with 3,696 drugs and 5,743 conditions by eHealthMe. Check the latest studies of Nausea and vomiting.
4,173 people reported to have side effects when taking Jadenu.
Among them, 176 people (4.22%) have Nausea and vomiting.
Among these 176 people:
How long have people been on Jadenu when they have Nausea and vomiting? *
What is the gender of people who have Nausea and vomiting when taking Jadenu? *
What is the age of people who have Nausea and vomiting when taking Jadenu? *
What are other drugs people take besides Jadenu? *
What are other side effects people have besides Nausea and vomiting? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Jadenu and have Nausea and vomiting?
- Check whether Nausea and vomiting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Jadenu:
- Jadenu (4,176 reports)
Nausea and vomiting treatments and more:
- Nausea and vomiting (529,395 reports)
How severe was Nausea and vomiting and when was it recovered:
Expand to all the drugs that have ingredients of deferasirox:
- Nausea and vomiting and drugs with ingredients of deferasirox (1,841 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Jadenu:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Nausea and vomiting:
- Nausea and vomiting (3,696 drugs)
Browse all the conditions that are associated with Nausea and vomiting:
- Nausea and vomiting (5,743 conditions)
Related publications that referenced our studies
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on deferasirox (the active ingredients of Jadenu) and Jadenu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Testosterone Cypionate cause Penis Pain? - 9 seconds ago
- Could Albuterol cause Accidental Exposure? - 10 seconds ago
- Could Lariam cause Fatigue Aggravated? - 19 seconds ago
- Could Clindamycin Phosphate cause Folliculitis? - 23 seconds ago
- Could Ortho Evra cause Menstrual Disorder? - 23 seconds ago
- Drug interactions of Acthar and Cyclophosphamide - 27 seconds ago
- Could Enalapril Maleate cause Cardiac Valve Disease? - 31 seconds ago
- Could Dalfampridine cause Abdominal Pain? - 32 seconds ago
- Could Ipratropium Bromide cause Subdural Haematoma? - 32 seconds ago
- Could Se cause Knee Joint Replacement? - 35 seconds ago